tiprankstipranks

Arch Venture Fund Vii Lp Insider Profile

4 Followers
Arch Venture Fund Vii Lp, Ten Percent Owner at Juno Therapeutics, holds 11.55M shares in Juno Therapeutics (Ticker: JUNO), holds ― shares in Pulmatrix (Ticker: PULM), holds 5.73M shares in 908 Devices (Ticker: MASS).
tipranks
Arch Venture Fund Vii Lp

Arch Venture Fund Vii Lp
Juno Therapeutics (JUNO)
Ten Percent Owner

Ranked #95,346 out of 98,743 Corporate Insiders

Profitable Transactions

50%
3 out of 6 Profitable Transactions

Average Return

-79.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$185M
54.71%
17.62%
14.89%
11.80%
0.98% Others
A breakdown of Arch Venture Fund Vii Lp's holdings

Insider Roles

Agios Pharma
(AGIO)
Ten Percent Owner
908 Devices
(MASS)
Ten Percent Owner
SAGE Therapeutics
(SAGE)
Ten Percent Owner
Syros Pharmaceuticals
(SYRS)
Ten Percent Owner
+2 other positions
Roles that Arch Venture Fund Vii Lp holds in companies

Most Profitable Insider Trade

Stock:
Juno Therapeutics
(JUNO)
Rating:Informative Buy
Date:Dec 18, 2014 - Dec 18, 2015
Return:+85.90%
The most profitable trade made by Arch Venture Fund Vii Lp

Arch Venture Fund Vii Lp's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
JUNO
Juno Therapeutics
Mar 17, 2016
Uninformative Sell
$1.00B
Pulmatrix
Former 10% Owner
Syros Pharmaceuticals
Jul 17, 2019
Ten Percent Owner
Informative Sell
488.84K
$21.85M
908 Devices
Dec 22, 2020
Ten Percent Owner
Uninformative Buy
$32.63M
Agios Pharma
Feb 23, 2015
Ten Percent Owner
Uninformative Sell
$101.31M
SAGE Therapeutics
Jun 20, 2015
Ten Percent Owner
Uninformative Sell
$27.58M
Bluebird Bio
Jun 26, 2013
Ten Percent Owner
Uninformative Buy
$1.81M
RCPT
Receptos
May 15, 2014
Informative Sell
1.35M
$477.52M
List of latest transactions for each holding click on a transaction to see Arch Venture Fund Vii Lp's performance on stock

Arch Venture Fund Vii Lp insider profile FAQ

What is the percentage of profitable transactions made by Arch Venture Fund Vii Lp?
The percentage of profitable transactions made by Arch Venture Fund Vii Lp is 50%.
    What is the average return per transaction made by Arch Venture Fund Vii Lp?
    The average return per transaction made by Arch Venture Fund Vii Lp is -79.40%.
      What stocks does Arch Venture Fund Vii Lp hold?
      Arch Venture Fund Vii Lp holds: JUNO, PULM, SYRS, MASS, AGIO, SAGE, BLUE, RCPT stocks.
        What was Arch Venture Fund Vii Lp’s latest transaction?
        Arch Venture Fund Vii Lp latest transaction was an Uninformative Sell of ―.
          What was Arch Venture Fund Vii Lp's most profitable transaction?
          Arch Venture Fund Vii Lp’s most profitable transaction was an Informative Buy of JUNO stock on December 18, 2014. The return on the trade was 85.90%.
            What is Arch Venture Fund Vii Lp's role in Juno Therapeutics?
            Arch Venture Fund Vii Lp's role in Juno Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.